How to Use Primary Cells to Develop the Next Therapy
Human primary cells are cells isolated directly from tissues, including blood and bone marrow. The use of human primary cells increases the physiological relevance of cell culture systems, enabling you to generate meaningful data that is more predictive of in vivo outcomes. Learn about the advantages of starting with human primary cells for your immunology and cell therapy research workflows. Key considerations for choosing the ideal starting material, donor characterization, regulatory challenges, and tips to streamline your cell-based assays with human primary and cultured cells are also covered.
Scaling Biomimetic Culture of Pluripotent Stem Cells
Hear from Dr. Maxime Feyeux, who discusses what the in vivo growth environment of pluripotent stem cells (PSCs) can teach us about in vitro culture. He summarizes some of the current challenges facing standard PSC culture technologies and shares a solution for mass producing high-quality PSCs for downstream applications.
“Developing Regenerative Medicines” Featuring Dr. Stefan Irion
On this episode of the Stem Cell Podcast, Dr. Stefan Irion from BlueRock Therapeutics discusses the company’s Parkinson’s disease trial and the challenges of genetically manipulating stem cells.
“Accelerating Stem Cell Treatments” Featuring Dr. Maria Millan
On this episode of the Stem Cell Podcast, Dr. Maria Millan from the California Institute for Regenerative Medicine (CIRM) talks about her transition from surgeon to stem cell specialist, how California culture has helped CIRM to thrive, and its role in training the next generation of stem cell scientists.
“Printing Human Tissues” Featuring Dr. Anthony Atala
On this episode of the Stem Cell Podcast, Dr. Anthony Atala from the Wake Forest Institute for Regenerative Medicine discusses tissue engineering, vascularization, and prioritizing safety when studying lab-grown organs.
EasySep™小鼠TIL（CD45）正选试剂盒
How to Use Primary Cells to Develop the Next Therapy Human primary cells are cells isolated directly from tissues, including blood and bone marrow. The use of human primary cells increases the physiological relevance of cell culture systems, enabling you to generate meaningful data that is more predictive of in vivo outcomes. Learn about the advantages of starting with human primary cells for your immunology and cell therapy research workflows. Key considerations for choosing the ideal starting material, donor characterization, regulatory challenges, and tips to streamline your cell-based assays with human primary and cultured cells are also covered.
Scaling Biomimetic Culture of Pluripotent Stem Cells Hear from Dr. Maxime Feyeux, who discusses what the in vivo growth environment of pluripotent stem cells (PSCs) can teach us about in vitro culture. He summarizes some of the current challenges facing standard PSC culture technologies and shares a solution for mass producing high-quality PSCs for downstream applications.
“Developing Regenerative Medicines” Featuring Dr. Stefan Irion On this episode of the Stem Cell Podcast, Dr. Stefan Irion from BlueRock Therapeutics discusses the company’s Parkinson’s disease trial and the challenges of genetically manipulating stem cells.
“Cellular Reprogramming and Pluripotency” Featuring Dr. Jacob Hanna On this episode of the Stem Cell Podcast, Dr. Jacob Hanna from the Weizmann Institute of Science discusses his research on synthetic embryo models.
“Accelerating Stem Cell Treatments” Featuring Dr. Maria Millan On this episode of the Stem Cell Podcast, Dr. Maria Millan from the California Institute for Regenerative Medicine (CIRM) talks about her transition from surgeon to stem cell specialist, how California culture has helped CIRM to thrive, and its role in training the next generation of stem cell scientists.
“ISSCR 2022: 20 Years of Excellence” Featuring Dr. Melissa Little, Keith Alm, and Dr. Amander Clark On this episode of the Stem Cell Podcast, Dr. Melissa Little, Keith Alm, and Dr. Amander Clark from the International Society for Stem Cell Research (ISSCR) discuss the ISSCR 2022 annual meeting, and the future of the organization and the stem cell research community.
“Printing Human Tissues” Featuring Dr. Anthony Atala On this episode of the Stem Cell Podcast, Dr. Anthony Atala from the Wake Forest Institute for Regenerative Medicine discusses tissue engineering, vascularization, and prioritizing safety when studying lab-grown organs.
